NEW YORK, Sept. 28 (GenomeWeb News) - Nanogen expects to raise nearly $20 million through a stock offering to institutional investors scheduled to close today, the company said.
The San Diego-based company will sell 6.8 million shares of its common stock to investors at a price of nearly $3 per share, with 1 million warrants exercisable at $4 per share for five years.
...and receive Daily News bulletins.
Already have an account?Login Now.
The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.
Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.
In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.
At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.